Belharra Therapeutics
Biotechnology Research • 
San Diego, California, United States • 21-50 Employees
Company overview
| Headquarters | 3985 Sorrento Valley Blvd, San Diego, California 92121, US |
| Phone number | +18588004340 |
| Website | |
| NAICS | 541714 |
| Keywords | Research, Drug Discovery, Chemoproteomics |
| Founded | 2021 |
| Employees | 21-50 |
| Socials |
Key Contacts at Belharra Therapeutics
Yvonne Schmidt
Senior Director
Jessica Alexander
Senior Director Program And Alliance Management
Andrew C. Wang
Director Of Platform
Belharra Therapeutics Email Formats
Belharra Therapeutics uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@belharratx.com), used 63.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@belharratx.com | 63.9% |
{first name}{last name} | johndoe@belharratx.com | 27.8% |
{last name}{last name} | doedoe@belharratx.com | 8.3% |
About Belharra Therapeutics
Belharra Therapeutics, Inc.is a privately helddrug discovery company whose novelphotoaffinity-based chemoproteomics platformis disrupting the drug discovery paradigm. Guided by a diverse team ofbiotech trailblazers, Belharra’s proprietary noncovalentdrug discovery engine is uniquelycapable of identifyingnovel starting points fortransformative medicinesto addresspreviously impossible-to-treat diseases and conditions. The company’s next generation chemoproteomics platform enables Belharra scientists to identify small molecule drug candidates for any binding site, on any protein, in any conformational state, in any cell type. Originating with Christopher G. Parker, Ph.D.and John Teijaro, Ph.D.atScripps Research and pioneers in the field of chemical biology and serial biotech founders Benjamin Cravatt, Ph.D.atScripps Researchand Stuart Schreiber, Ph.D.at the Broad Institute of MIT and Harvard,the four co-foundedBelharra Therapeutics in2021 with a $50M Series A financing from Versant Ventures and incubation at Inception Therapeutics. Belharra isheadquartered inthe San Francisco Bay Areawith its primary lab and offices in San Diego, California.
Belharra Therapeutics revenue & valuation
| Annual revenue | $250,000 |
| Revenue per employee | $7,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $800,000 |
| Total funding | $50,000,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Belharra Therapeutics has 7 employees across 4 departments.
Departments
Number of employees
Belharra Therapeutics Tech Stack
Discover the technologies and tools that power Belharra Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
Font scripts
Security
JavaScript libraries
Hosting
Form builders
Miscellaneous
Programming languages
Blogs
Marketing automation
JavaScript libraries
JavaScript libraries
Spain
Philippines
Belgium
PolandFrequently asked questions
4.8
40,000 users
